fate therapeutics stock price target

FATE stock quote history news and other vital information to help you with your stock trading and investing. FATE stock analyst estimates including earnings and revenue EPS upgrades and downgrades.

Fate Therapeutics Nasdaq Fate Quotes And News Summary Benzinga

The Fate Therapeutics stock prediction results are shown below and presented as a graph table and text information.

. Based On Fundamental Analysis. Wedbush increased their price target on shares of Fate Therapeutics from 7400 to 7700 and gave the stock an outperform rating in a research note on Tuesday March 1st. Find the latest analyst research for Fate Therapeutics Inc.

Whats Happening With Fate Therapeutics Inc Stock Today. FATE updated stock price target summary. FATE were skyrocketing 473 higher as of 1143 am.

FATE has a greater upside potential average analyst target price relative to current price than 149379 of stocks in the mid market cap category. Revenue growth over the past 12 months for Fate Therapeutics Inc comes in at 7766 a number that. Ad Our Strong Track Record Has Enabled Us To Become A Leader In Rare Disease.

Find the latest Fate Therapeutics Inc. On average they predict Fate. According to the issued ratings of 11 analysts in the last year the consensus rating for Fate Therapeutics stock is Buy based on the current 3 hold ratings and 8 buy ratings for.

Shares of Fate Therapeutics stock opened at 2310 on Monday. Fate Therapeutics Inc. Fate Therapeutics has a 52-week low of 2049 and a 52-week high of 9743.

FATEs pricesales ratio is 7242. For Fate Therapeutics stock forecast for 2025 12 predictions are. 7 2020 at 750 am.

11 Wall Street analysts have issued 1 year target prices for Fate Therapeutics stock. The Score for FATE is 48 which is 4 below its historic median score of 50 and infers higher risk than normal. We Are Well Positioned to Deliver Sustainable Top-Tier Growth Enhanced Shareholder Value.

For ratings consensus and a summary of stock price. 7 Wall Street analysts that have issued a 1 year FATE price target the average FATE price target is 7643. In terms of how Fate Therapeutics Inc.

The huge jump came after the biotech. Wall Street is positive on Fate Therapeutics Inc On average analysts give the stock a Strong Buy rating. The average FATE THERAPEUTICS stock price prediction.

Stock Price Target FATE. NASDAQFATEs beta value is holding at 169 while the average true range ATR indicator is currently reading 234. Their forecasts range from 2800 to 11600.

Negative dynamics for Fate Therapeutics shares will prevail with possible. Fate Therapeutics stock price target raised to 79 from 58 at Stifel Nicolaus. Which would more than double the current price.

47 rows Close price at the end of the last trading day Friday 20th May 2022 of the FATE stock was 2310. The average Fate Therapeutics stock forecast 2023 represents a -4862 decrease from the last price of 38689998626709. We Are Well Positioned to Deliver Sustainable Top-Tier Growth Enhanced Shareholder Value.

View FATE revenue estimates and earnings estimates as well as in-depth analyst breakdowns. Fate Therapeutics Inc. Forecast target price for 04-29-2022.

Thats higher than the PS ratio of 9704 of US stocks. Analyst ratings historical stock prices earnings estimates actuals. The stock has a.

Research and ratings by Barrons. Fate Therapeutics Inc FATE stock is trading at 6135 as of 1146 AM on Thursday Dec 30 a rise of 213 or 359. What happenedShares of Fate Therapeutics NASDAQ.

Stock Price Forecast The 20 analysts offering 12-month price forecasts for Fate Therapeutics Inc have a median target of 8200 with a high estimate of 13500 and a low estimate of 2800. NasdaqGM - NasdaqGM Real Time Price. According to 26 stock analysts the average 12-month stock.

FATE IEX Real-Time Price USD. The average price target is 107533 which means analysts expect. Fate Therapeutics Stock Forecast 04-29-2022.

This is 313 more than the trading day before Thursday 19th. Ad Our Strong Track Record Has Enabled Us To Become A Leader In Rare Disease. Fate Therapeutics stock forecasts are adjusted once a day.

Based on the current price of 2047 the target price of 8500 shows a potential of 315242 for Fate Therapeutics Inc. The average price target is 000 with a high estimate of. See Fate Therapeutics Inc.

Ad Our Strong Buys Double the SP. ET by Tomi Kilgore. The current Fate Therapeutics Inc FATE share price is 2310.

Fate Therapeutics stock price target raised to 88 from 55 at.

Fate Therapeutics Inc Shares Close The Day 11 4 Lower Daily Wrap Nasdaq

Fate Therapeutics Jumped On Supportive Trial Data Nasdaq Fate Seeking Alpha